Biden Signs $137 Million Deal with German Company for Covid Tests to Deliver in Late 2024…
Should we be on the watch? Didn’t they say they’re canceling COVID tests due to the fact they were showing positive results for over 12 weeks?
Join The True Defender Telegram Chanel Here: https://t.me/TheTrueDefender
But why in the election year exactly?
That raises a few questions:
– Why didn’t Biden order tests from an American company?
– Why does Biden think we will still have COVID in 2024?
– Why didn’t Biden order tests to be delivered immediately?
Don’t you want the answers to these questions?
Today, I committed $137 million to expanding the production of COVID-19 at-home tests using our military authority in order to meet demand. https://t.co/eNmA4CCkkR
— President Biden (@POTUS) December 30, 2021
Biden signs $137 million deal with German pharmaceutical company for COVID test strip factory that will take THREE YEARS to build and will start producing 83.3 million tests a month in late 2024 at the earliest https://t.co/SPgQvrrTOJ
— Hunting Wolf In PA (@SlayerWolf11) December 30, 2021
While you wait two hours in line for a COVID test, pay $75 to fill your gas tank, or can’t find basic needs because of supply chain issues… just rest assured that Joe Biden has it all under control from his beach vacation home in Delaware
— Mark Meadows (@MarkMeadows) December 29, 2021
“The Biden administration struck a $137 million deal to build a new factory in the U.S. to ramp up production of COVID-19 testing kits – but the new facility won’t be completed until late 2024 at the earliest,” The Daily Mail reported.
“MilliporeSigma, a brand formed by Germany’s Merck KGaA, will build a new factory in Sheboygan, Wisconsin, the Defense Department announced as the U.S. hit a high record of 489,267 COVID cases on Wednesday
While the contract gives the company three years to complete the facility, it is not immediately clear when it will ramp-up to full production, which is expected to pump out 83.3 million tests per month.
‘Construction is expected to begin the second half of 2022 and initial planning and preparatory work is already underway,’ a MilliporeSigma spokesperson told DailyMail.com. ‘We estimate that the facility will be capable of providing lateral flow membranes in the latter part of 2024.’
The individual said that the production of lateral flow membrane is ‘critical for rapid diagnostic tests’ that will not only help with COVID-19 detection, but also with ‘any future public health emergencies.”
We demand transparency from our leaders!
Tell us the question you wish to be answered?
